These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36203566)

  • 1. Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor Program.
    Farhadfar N; Newman J; Novakovich J; Barten J; Ndifon ET; Oakes J; Cody M; Pham HP; Auletta JJ; Miller JP; Devine SM; Stefanski HE
    Front Immunol; 2022; 13():937900. PubMed ID: 36203566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products.
    Auletta JJ; Novakovich JL; Stritesky GL; Newman J; Fridy-Chesser ST; Hailperin K; Devine SM
    Transplant Cell Ther; 2021 Feb; 27(2):133-141. PubMed ID: 33830022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic.
    Hsu JW; Farhadfar N; Murthy H; Logan BR; Bo-Subait S; Frey N; Goldstein SC; Horowitz MM; Lazarus H; Schwanke JD; Shah NN; Spellman SR; Switzer GE; Devine SM; Shaw BE; Wingard JR
    Transplant Cell Ther; 2021 Jun; 27(6):507-516. PubMed ID: 33865804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryopreservation of Unrelated Hematopoietic Stem Cells from a Blood and Marrow Donor Bank During the COVID-19 Pandemic: A Nationwide Survey by the Japan Marrow Donor Program.
    Kanda Y; Inoue M; Uchida N; Onishi Y; Kamata R; Kotaki M; Kobayashi R; Tanaka J; Fukuda T; Fujii N; Miyamura K; Mori SI; Mori Y; Morishima Y; Yabe H; Kodera Y
    Transplant Cell Ther; 2021 Aug; 27(8):664.e1-664.e6. PubMed ID: 33964514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryopreservation of Allogeneic Hematopoietic Cell Products During COVID-19 Pandemic: Graft Characterization and Engraftment Outcomes.
    Keyzner A; Azzi J; Jakubowski R; Sinitsyn Y; Tindle S; Shpontak S; Kwon D; Isola L; Iancu-Rubin C
    Transplant Proc; 2023 Oct; 55(8):1799-1809. PubMed ID: 37210273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic.
    Laroye C; Thilly N; Gauthier M; Luc A; Latger-Cannard V; Eschwege V; Bensoussan D; Pochon C; Campidelli A; Rubio MT; D'Aveni M; Decot V
    Cytotherapy; 2023 Aug; 25(8):877-884. PubMed ID: 37178096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryopreservation of Growth Factor-Mobilized Peripheral Blood Stem Cells Does Not Compromise Major Outcomes after Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience.
    Connelly-Smith L; Gooley T; Roberts L; Mielcarek M; Linenberger M; Petersdorf E; Sandmaier BM; Milano F
    Transplant Cell Ther; 2023 Nov; 29(11):700.e1-700.e8. PubMed ID: 37659695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic.
    Purtill D; Hutchins C; Kennedy G; McClean A; Fraser C; Shaw PJ; Chiappini P; Tao H; Ma DD; Kabani K; Bai L; Greenwood M; Bajel A; O'Flaherty E; Curtis DJ; Purins L; Perera T; Tan S; Butler A; Micklethwaite K; Antonenas V; Gottlieb D; Hamad N
    Transplant Cell Ther; 2021 Dec; 27(12):1022.e1-1022.e6. PubMed ID: 34571211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal.
    Valentini CG; Chiusolo P; Bianchi M; Metafuni E; Orlando N; Giammarco S; Bacigalupo A; Sica S; Teofili L
    Cytotherapy; 2021 Jul; 23(7):635-640. PubMed ID: 33423867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Cryopreservation in Unrelated Bone Marrow and Peripheral Blood Stem Cell Transplantation in the Era of the COVID-19 Pandemic: An Update from the Japan Marrow Donor Program.
    Kanda Y; Doki N; Kojima M; Kako S; Inoue M; Uchida N; Onishi Y; Kamata R; Kotaki M; Kobayashi R; Tanaka J; Fukuda T; Fujii N; Miyamura K; Mori SI; Mori Y; Morishima Y; Yabe H; Atsuta Y; Kodera Y
    Transplant Cell Ther; 2022 Oct; 28(10):677.e1-677.e6. PubMed ID: 35803526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts.
    Jacob RP; Flynn J; Devlin SM; Maloy M; Giralt SA; Maslak P; O'Reilly RJ; Tonon JA; Perales MA; Avecilla ST; Cho C
    Transplant Cell Ther; 2021 Aug; 27(8):697.e1-697.e5. PubMed ID: 33991721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?
    Fernandez-Sojo J; Azqueta C; Valdivia E; Martorell L; Medina-Boronat L; Martínez-Llonch N; Torrents S; Codinach M; Canals C; Elorza I; Parody R; Martino R; Trabazo M; Díaz de Heredia C; Ferra C; Valcárcel D; Linares M; Ancochea Á; García-Rey E; García-Muñoz N; Medina L; Castillo N; Carreras E; Villa J; Querol S
    Bone Marrow Transplant; 2021 Oct; 56(10):2489-2496. PubMed ID: 34127808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic.
    Devine SM; Bo-Subait S; Kuxhausen M; Spellman SR; Bupp C; Ahn KW; Stefanski HE; Auletta JJ; Logan BR; Shaw BE
    Blood Adv; 2023 Oct; 7(19):5982-5993. PubMed ID: 37036959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation.
    Worel N; Shaw BE; Aljurf M; Koh M; Seber A; Weisdorf D; Schwartz J; Galeano S; Kodera Y; Eldridge PW; Hashmi S; Atsuta Y; Szer J; Saber W; Niederwieser D; Greinix HT;
    Transplant Cell Ther; 2021 Mar; 27(3):270.e1-270.e6. PubMed ID: 33781537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-thymocyte globulin and post-transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts.
    Novitzky-Basso I; Remberger M; Chen C; Pasić I; Lam W; Law A; Gerbitz A; Viswabandya A; Lipton JH; Kim DD; Kumar R; Mattsson J; Michelis FV
    Eur J Haematol; 2022 Jan; 108(1):61-72. PubMed ID: 34606661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of allogeneic cryopreserved hematopoietic cell grafts during the Covid-19 pandemic: A National Marrow Donor Program perspective.
    Devine SM
    Am J Hematol; 2021 Feb; 96(2):169-171. PubMed ID: 33206414
    [No Abstract]   [Full Text] [Related]  

  • 17. Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS.
    Mengling T; Rall G; Bernas SN; Astreou N; Bochert S; Boelk T; Buk D; Burkard K; Endert D; Gnant K; Hildebrand S; Köksaldi H; Petit I; Sauter J; Seitz S; Stolze J; Weber K; Weber M; Lange V; Pingel J; Platz A; Schäfer T; Schetelig J; Wienand E; Geist S; Neujahr E; Schmidt AH
    Bone Marrow Transplant; 2021 Apr; 56(4):798-806. PubMed ID: 33219340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A DKMS (German Bone Marrow Donor Center) view on cryopreservation of unrelated donor stem cell products during the Covid-19 pandemic.
    Schmidt AH; Buk D; Bernas SN; Mengling T; Neujahr E; van den Brink MRM
    Am J Hematol; 2021 Mar; 96(3):E91-E92. PubMed ID: 33368593
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of Covid 19 pandemic on hematopoietic stem cell transplantation activities: Report from a single center.
    Giammarco S; Sica S; Metafuni E; Limongiello MA; Valentini CG; Sorà F; Marra JD; Bacigalupo A; Teofili L; Chiusolo P
    Transfus Apher Sci; 2023 Aug; 62(4):103708. PubMed ID: 37003931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution.
    Maurer K; Kim HT; Kuczmarski TM; Garrity HM; Weber A; Reynolds CG; Liney D; Cutler C; Antin JH; Koreth J; Ritz J; Shapiro RM; Romee R; Wu CJ; Soiffer RJ; Nikiforow S; Ho VT; Gooptu M
    Blood Adv; 2021 Dec; 5(23):5140-5149. PubMed ID: 34581754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.